A Win For Calithera Biosciences, Inc.
Tue, Aug 06, 2024 at 07:03 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) jumped higher at $0.02, a gain of 80%. On Tue, Aug 06, 2024, CALA:NASDAQ touched a New 2-Week High of $0.02. From Tue, Jul 23, 2024, the stock recorded 28.57% Up Days and 0.00% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- VBI Vaccines Inc. (VBIV:NASDAQ), 111.29%
- Lumen Technologies Inc. (LUMN:NYSE), 93.05%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 80%
- Lytus Technologies Holdings PTV. Ltd. (LYT:NASDAQ), 52.45%
- Recon Technology, Ltd. (RCON:NASDAQ), 50%
- Clene Inc. (CLNN:NASDAQ), 47%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 45.16%
- MultiPlan Corporation Class A (MPLN:NYSE), 44.13%
- VSee Health Inc Com (VSEE:NASDAQ), 34.08%
- Bioventus Inc. (BVS:NASDAQ), 29.23%